Related Experiment Videos
The regulation of the complement system: insights from genetically-engineered mice
Daniel Turnberg1, Marina Botto
1Rheumatology Section, Division of Medicine, Faculty of Medicine, Imperial College, Hammersmith Campus, Du Cane Road, London W12 0NN, UK.
Molecular Immunology
|August 14, 2003
Summary
Genetically engineered animals reveal the crucial roles of complement inhibitors in preventing self-tissue damage. Studying these models offers valuable insights into complement system regulation and its therapeutic potential.
Area of Science:
- Immunology
- Molecular Biology
Background:
- The complement system is a critical part of innate immunity, requiring strict regulation to prevent autoinflammation.
- Fluid-phase and membrane-bound inhibitors are essential for controlling complement activation and protecting host tissues.
Purpose of the Study:
- To review the insights gained from studying genetically engineered animal models with altered complement inhibitor function.
- To discuss the advantages and disadvantages of using these animal models to understand complement biology in vivo.
Main Methods:
- Investigation of genetically engineered animals with targeted deletion or gain-of-function mutations in complement inhibitor genes.
- Review of existing literature and data from studies utilizing these animal models.
Main Results:
- Genetically modified animal studies have underscored the in vivo significance of various complement inhibitors.
- These models have illuminated the complex regulatory network governing complement activation and its impact on self-tissue integrity.
Conclusions:
- Genetically engineered animal models are powerful tools for dissecting the in vivo functions of complement inhibitors.
- Understanding complement regulation through these models is vital for developing therapies for complement-mediated diseases.